Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2003

Calprotectin in the modern diagnosis of Inflammatory Bowel Disease and neoplasms

Adam Szarszewski, Maria Korzon, Anna Liberek, Barbara Kamińska, Maciej Zagierski

Med Sci Monit 2003; 9(4): 60-63 :: ID: 428646

Abstract

Inflammatory Bowel Disease (IBD) and colorectal neoplasms have become recently real diagnostic and therapeutical problems. New research methods are needed, which can help simplify the diagnosis process. Detection of calprotectin in the feaces is expected to become a screening test for IBD and colorectal neoplasms. Calprotectin, a complex calcium binding protein belongs to a major family of proteins produced during the inflammatory process. Calprotectin is produced mainly by neutrophils, but also by monocytes and epithelial cells during inflammatory state, when it can consist up to 60% of cytoplasm. Three groups of patients have been established, in whom level of calprotectin excreted in faeces is significantly higher than in healthy individuals, i.e. patients with IBD, patients with colorectal neoplasms and patients after therapy with non-steroid anti-inflammatory drugs (NSAID). Measurement of calprotectin in feaces can become a valuable diagnostic method in all these conditions thanks to calprotectin stability in feaces and the low cost of the test. In the pediatric population it seems especially important in the children with IBD and, according to many authors, this method has high sensitivity and specificity in this population. It can be useful both in diagnosis of IBD and in monitoring of severity of the process. It seems that the calprotectin test could become a valuable test in patients suspected of IBD or colorectal neoplasm and thus become important addition to colonoscopy, imaging methods and histopathology examinations.

Keywords: calprotectin, ulcerative colitis, Crohn Disease, Colorectal Carcinoma

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750